Mercury in vaccines from the australian childhood immunization program schedule

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 73, Issue 10, 2010, Pages 637-640

  Austin, David W ^a   Shandley, Kerrie A ^a   Palombo, Enzo A ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; MERCURY; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; THIOMERSAL; UNCLASSIFIED DRUG; VACCINE; VARILIX;

ANALYZER; ARTICLE; CONTENT ANALYSIS; DRUG EXPOSURE; DRUG SAFETY; FOLLOW UP; HUMAN; IMMUNIZATION; PATIENT SAFETY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; VACCINE PRODUCTION;

AUSTRALIA; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION; INFANT; MERCURY; PRESERVATIVES, PHARMACEUTICAL; SPECTROPHOTOMETRY, ATOMIC; VACCINES;

EID: 77951218521     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287391003613994     Document Type: Article

References (9)

1. Australian Government Department of Health and Ageing Therapeutic Goods Administration. 2003. Australian guideline for pharmacovigilance responsibilities of sponsors of registered medicines regulated by drug safety and evaluation branch (July 2003-amended 31 May 2005). Canberra: Australian Government Department of Health and Ageing. http://www.tga.gov.au/adr/pharmaco. pdf
2. Australian Technical Advisory Group on Immunisation. 2008. The Australian immunisation handbook, 9th ed. Canberra: Australian Government Department of Health and Ageing. http://immunise.health.gov.au/internet/ immunise/publishing. nsf/Content/handbookhome
3. Dietert, R. R., and Dietert, J. M. 2008. Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: Focus on critical windows of immune vulnerability. J. Toxicol. Environ. Health B 11:660-680.
4. Ehreth, J. 2003. The value of vaccination: A global perspective. Vaccine. 21:4095-4104. (Pubitemid 37130255)
5. Geier, D. A., and Geier, M. R. 2006. An evaluation of the effects of thimerosal on neurdevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States. J. Toxicol. Environ. Health A 69:1481-1495.
6. Geier, D. A., Sykes, L. K., and Geier, M. R. 2007. A review of thimerosal (merthiolate) and its ethymercury breakdown product: Specific historical considerations regarding safety and effectiveness. J. Toxicol. Environ. Health B 10:575-596.
7. National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. 2007a. Childhood immunisation coverage. Sydney: University of Sydney. http://www.health.gov.au/internet/main/ publishing.nsf/Content/cda- cdi3302c.htm
8. National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. 2007b. Thiomersal fact sheet. Sydney: University of Sydney. http://www.ncirs.usyd. edu.au/immunisation/fact-sheets/thiomersalfact- sheet.pdf
9. U.S. Environmental Protection Agency. 2009. Methylmercury (MeHg) (CASRN 22967-92-6). http://www.epa.gov/iris/subst/0073.htm